As the landscape of contraceptive care evolves, pharmacists are increasingly playing a pivotal role in helping patients navigate new and existing oral contraceptive options. With recent changes in BC PharmaCare coverage and the introduction of new prescription options, pharmacy professionals need to stay current and confident in their approach to counselling.
Join us for a timely and practical session with Dr. Jane Xia as we explore the latest developments in oral contraceptive prescribing. Through real-world insights and patient-focused strategies, Dr. Xia will walk participants through how to assess patient needs, evaluate hormonal and progestin-only contraceptives, and recommend suitable options based on individual circumstances and provincial coverage.
Whether you're just starting to prescribe or looking to enhance your approach to contraceptive care, this session is designed to equip pharmacists, technicians, and students with the tools and knowledge to support patients confidently and effectively in the community setting.
Learning Objectives
At the end of the webinar, pharmacists will be able to:
- Compare Different Oral Contraceptive Options: Identify and distinguish between various hormonal contraceptives, including their benefits and drawbacks.
- Assess Patient Needs for Oral Contraceptive Options: Determine when a patient needs new contraceptive advice and how to engage with them effectively.
- Evaluate Oral Progestin-Only Contraceptives: Explain the advantages of progestin-only contraceptives, including fewer side effects and a longer missed-pill window.
- Recognize the latest prescription contraceptives added to BC PharmaCare: Assess when to recommend them based on patient needs.
About the Speaker: Jane Xia
Dr. Jane Xia joined the Faculty of Pharmaceutical Sciences in January 2019. She earned her Bachelor of Science in Pharmacy from the University of British Columbia, her MBA from Simon Fraser University, and her PharmD from the University of Toronto.
Dr. Xia has practiced in various areas of pharmacy, including community, hospital, regulatory, and industry settings. While working at Merck and Boehringer Ingelheim, she built strong, collaborative relationships with physicians and other healthcare professionals. In 2018, Dr. Xia and her team at London Drugs launched the Hepatitis C Screening Program in selected community pharmacies, following the successful establishment of partnerships with patient advocacy groups, healthcare teams, and specialists.
Dr. Xia’s current research interests include patient journeys in chronic diseases and business in healthcare, with a clinical focus on women’s health.
Learning Hours
This program is non-accredited. Total learning hours is estimated at 1.0 hour. Participants will receive a letter of participation after completing a survey at the end of the webinar.
This learning program received a financial support from Duchesnay Canada. This event will be moderated by a member of our Pharmacy Practice Support team at the BC Pharmacy Association.
Registration Information
A BCPhA account is required to register for this event. If you do not have a login account or if you are unsure if you have a login, please fill out the Account Creation Form and a member of the BCPhA team will contact you. Accounts can be created free of charge with valid College registration.
Registration closes an hour prior to the start of the webinar, at 5:00 PM. On the day of the webinar, you will receive a link to the webinar by email. The email will come from noreply@zoom.us and could be in your junk folder.